Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Multi-Residue Analysis of Abuse Drugs in Whole Blood Using In-well Protein Precipitation Followed with Captiva EMR-Lipid Cleanup by LC-MS/MS
Limian Zhao
Agilent Technologies

DescriptionY/NSource
Grantsno
Salaryyes
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

yes